1-888-330-3964
FREE Shipping over $599!

1 FREE box of needles with orders over $599!

Syringe: Cortical Mineralized/Demineralized Blend

Updated 2020-10-19
SKU:
raptos-DMC02S-02-DMC02S-05-DMC02S-10
Manufacturer:
Citagenix

This Cortical Mineralized/Demineralized Premium blend combines two popular allograft particles in a convenient syringe with a filter cap. The mineralized bone offers an osteoconductive platform for bone regeneration, while the demineralized particles offer an osteoinductive boost.

  • Contains: 70% Mineralized Cortical Bone/30% Demineralized Cortical Bone
  • Osteoinductive and Osteoconductive properties
  • 3 convenient sizes, 250 - 850 μm granule size
Important: This bone mix is cortical bone ONLY! If you are looking for Cortical Cancellous Bone Mix in a syringe, please see RAPTOS Prefilled Syringe: Mineralized Cortico-Cancellous Bone Graft options. This is NOT Cortical/Cancellous Mix. Do NOT order this, if you want Cortical/Cancellous Mix
This item is currently not in stock

Raptos syringe instructions

Raptos ® Allograft mineralized bone grafts offer an osteoconductive platform for bone regeneration and Raptos Demineralized Particles offer an osteoinductive boost. Used either alone or as part of a composite bone graft, allograft bone particulates supply a natural framework facilitating the attachment of osteogenic precursor cells. This Cortical Mineralized/Demineralized blend (70/30) combines two popular allograft particulates used in dentistry, all in a single syringe!

Raptos is provided in a specially designed syringe which enables rehydration in the syringe with saline or patient’s blood. Raptos is aseptically processed and provided in a powder and chip form, sterile, single patient use package.

  • Sourced from premier tissue bank
    Strict processing procedures are taken by the tissue bank to ensure quality and safe tissue grafts for transplantation. Tissue bank complies with guidelines and regulations with the American Association of Tissue Banks (AATB), Food and Drug and Administration (FDA) and state health department regulations.
  • DONOR ELIGIBILITY
    Donor eligibility (screening and testing) is performed in accordance
    with AATB standards and FDA regulations. Donor screening includes
    assessment of the medical and social history as well as physician
    assessment of the donor to assure that no conditions exist that may make
    the tissue unacceptable for transplantation. Donor eligibility has been
    determined by the Medical Director of the tissue bank (as identified on the
    product’s outer packaging).

  • SEROLOGICAL TESTING
    The following required testing was performed and found to be negative
    or non-reactive. Additional tests may have been performed at the time of
    donor screening, and were found to be acceptable for transplantation. A
    list of additional communicable disease test(s) performed will be provided
    upon request. Serological testing is performed using FDA-licensed test kit
    by a laboratory registered with FDA to perform donor testing and certified
    to perform such testing on human specimens in accordance with the
    clinical Laboratory Improvement Amendments of 1988 (CLIA) and 42CFR
    part 493, or that has met equivalent requirements as determined by the
    Centers for Medicare and Medicaid Services(CMS).
    • Antibodies to the human immunodeficiency virus, type 1 and type 2
    (anti-HIV-1 and anti-HIV-2)
    • Nucleic acid test (NAT) for HIV-1
    • Hepatitis B surface antigen (HBsAg)
    • Nucleic acid test (NAT) for the hepatitis B (HBV)
    • Total antibodies to hepatitis B core antigen (anti-HBc-total, meaning IgG
    and IgM)
    • Antibodies to the hepatitis C virus (anti-HCV)
    • Nucleic acid test (NAT) for HCV
    • Syphilis(a non-treponemal or treponemal-specific assay may be
    performed)

  • MICROBIAL TESTING
    Tissue is subjected to microbiological testing at recovery and in the
    course of processing, and must be free of specific aerobic / anaerobic
    microorganisms and fungal contaminants whose presence would
    preclude tissue processing or transplantation.

  • PATIENT RECORD AND TRACING
    Product recipient records must be maintained by the physician, transplant
    facility or hospital for the purpose of tracing tissue post-implantation. A
    Raptos Traceability record and peel-off chart labels have been included
    in the packaging of this product. This record must be completed at the
    time of the surgical procedure. Please record the name and address of the
    transplant facility, physician name, allograft tissue information (use a chart
    label), and comments on use of the Raptos. A copy of this form should be
    retained by the transplant facility or physician for future reference. The
    completed form must mailed or faxed back to your distributor. Even if the
    entire tissue product is discarded the Raptos Traceability record must be
    filled out, the reason for discarding the product must be noted and the
    record mailed or faxed back to your distributor.

  • Low dose gamma irradiation
    Musculoskeletal allografts are processed and sterilized using gamma irradiation, following ISO 11137 methodology to provide a sterility assurance level of 10-6

    Raptos is intended for single patient use only and was aseptically
    manufactured. After the complete processing and packaging procedure,
    Raptos has been sterilized by Electron Beam Irradiation. This irradiation
    procedure has been validated to reduce the level of bacterial and fungal
    contamination. DO NOT RE-STERILIZE.

  • Treated with patented cleaning treatment
    As part of a validated process, cleaning and disinfecting solutions such as alcohol, antibiotics and hydrogen peroxide, along with centrifuges, ultrasonic baths and pressure washes are used during a patented cleaning treatment, to remove viruses, bacteria and cellular material.

Sorry, we don't have any videos yet for this product. In the meantime, enjoy 2 of FREE CE Previews. Customers can now earn FREE CE.

More Information

Raptos syringe instructions

Raptos ® Allograft mineralized bone grafts offer an osteoconductive platform for bone regeneration and Raptos Demineralized Particles offer an osteoinductive boost. Used either alone or as part of a composite bone graft, allograft bone particulates supply a natural framework facilitating the attachment of osteogenic precursor cells. This Cortical Mineralized/Demineralized blend (70/30) combines two popular allograft particulates used in dentistry, all in a single syringe!

Raptos is provided in a specially designed syringe which enables rehydration in the syringe with saline or patient’s blood. Raptos is aseptically processed and provided in a powder and chip form, sterile, single patient use package.

  • Sourced from premier tissue bank
    Strict processing procedures are taken by the tissue bank to ensure quality and safe tissue grafts for transplantation. Tissue bank complies with guidelines and regulations with the American Association of Tissue Banks (AATB), Food and Drug and Administration (FDA) and state health department regulations.
  • DONOR ELIGIBILITY
    Donor eligibility (screening and testing) is performed in accordance
    with AATB standards and FDA regulations. Donor screening includes
    assessment of the medical and social history as well as physician
    assessment of the donor to assure that no conditions exist that may make
    the tissue unacceptable for transplantation. Donor eligibility has been
    determined by the Medical Director of the tissue bank (as identified on the
    product’s outer packaging).

  • SEROLOGICAL TESTING
    The following required testing was performed and found to be negative
    or non-reactive. Additional tests may have been performed at the time of
    donor screening, and were found to be acceptable for transplantation. A
    list of additional communicable disease test(s) performed will be provided
    upon request. Serological testing is performed using FDA-licensed test kit
    by a laboratory registered with FDA to perform donor testing and certified
    to perform such testing on human specimens in accordance with the
    clinical Laboratory Improvement Amendments of 1988 (CLIA) and 42CFR
    part 493, or that has met equivalent requirements as determined by the
    Centers for Medicare and Medicaid Services(CMS).
    • Antibodies to the human immunodeficiency virus, type 1 and type 2
    (anti-HIV-1 and anti-HIV-2)
    • Nucleic acid test (NAT) for HIV-1
    • Hepatitis B surface antigen (HBsAg)
    • Nucleic acid test (NAT) for the hepatitis B (HBV)
    • Total antibodies to hepatitis B core antigen (anti-HBc-total, meaning IgG
    and IgM)
    • Antibodies to the hepatitis C virus (anti-HCV)
    • Nucleic acid test (NAT) for HCV
    • Syphilis(a non-treponemal or treponemal-specific assay may be
    performed)

  • MICROBIAL TESTING
    Tissue is subjected to microbiological testing at recovery and in the
    course of processing, and must be free of specific aerobic / anaerobic
    microorganisms and fungal contaminants whose presence would
    preclude tissue processing or transplantation.

  • PATIENT RECORD AND TRACING
    Product recipient records must be maintained by the physician, transplant
    facility or hospital for the purpose of tracing tissue post-implantation. A
    Raptos Traceability record and peel-off chart labels have been included
    in the packaging of this product. This record must be completed at the
    time of the surgical procedure. Please record the name and address of the
    transplant facility, physician name, allograft tissue information (use a chart
    label), and comments on use of the Raptos. A copy of this form should be
    retained by the transplant facility or physician for future reference. The
    completed form must mailed or faxed back to your distributor. Even if the
    entire tissue product is discarded the Raptos Traceability record must be
    filled out, the reason for discarding the product must be noted and the
    record mailed or faxed back to your distributor.

  • Low dose gamma irradiation
    Musculoskeletal allografts are processed and sterilized using gamma irradiation, following ISO 11137 methodology to provide a sterility assurance level of 10-6

    Raptos is intended for single patient use only and was aseptically
    manufactured. After the complete processing and packaging procedure,
    Raptos has been sterilized by Electron Beam Irradiation. This irradiation
    procedure has been validated to reduce the level of bacterial and fungal
    contamination. DO NOT RE-STERILIZE.

  • Treated with patented cleaning treatment
    As part of a validated process, cleaning and disinfecting solutions such as alcohol, antibiotics and hydrogen peroxide, along with centrifuges, ultrasonic baths and pressure washes are used during a patented cleaning treatment, to remove viruses, bacteria and cellular material.

Questions and Answers
Videos

Sorry, we don't have any videos yet for this product. In the meantime, enjoy 2 of FREE CE Previews. Customers can now earn FREE CE.

Reviews

Contact

20801 Biscayne Boulevard, Suite 403 Aventura, FL 33180

888-330-3964